United States Biotechnology & Medical Research

Lexeo Therapeutics Inc (LXEO)

Track

Over the past 90 days, Lexeo Therapeutics insiders have engaged in significant selling activity, totaling approximately $568,320 in net sales. Key executives, including the CEO, CFO, and CMO, have offloaded shares. This trend coincides with a 30.2% decline in stock price, occurring after the company's May 2026 earnings report.
Ticker: LXEO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lexeo Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 1 Jul 2026
Value US$2,477,851.39 | Price 25.31 | Shares 20,564 (-34.9%)
Proposed sale 1 Jul 2026
Value US$2,033,823.37 | Price 329.44 | Shares 51,653
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-07-01 S Sale
Tamayo Louis Edward

Chief Financial Officer

Officer
20,564 -34.9%
25.31
US$2,477,851 		20,564 -34.9% 25.31 US$2,477,851
2026-07-01 2026-07-01 S Sale
2.5
Otero Jose Manuel

Chief Operating Officer

Officer
59,394 +43.2%
422.79
US$4,857,197 		59,394 +43.2% 422.79 US$4,857,197
2026-07-01 2026-07-01 S Sale
Bhalla Narinder Pal

Chief Medical Officer

Officer
37,063 -42.4%
185.56
US$4,870,264 		37,063 -42.4% 185.56 US$4,870,264
2026-07-01 2026-07-01 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
25,947 -6.4%
4.48
US$116,243 		25,947 -6.4% 4.48 US$116,243
2026-07-01 2026-07-01 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
4,666
4.48
US$20,919 		4,666 4.48 US$20,919
2026-07-01 2026-07-01 PrS Proposed sale
Bhalla Narinder Pal

Officer

Officer
22,306
4.42
US$98,684 		22,306 4.42 US$98,684
2026-07-01 2026-07-01 PrS Proposed sale
Tamayo Louis Edward

Officer

Officer
4,641
4.49
US$20,815 		4,641 4.49 US$20,815
2026-07-01 2026-07-01 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
25,947
4.48
US$116,185 		25,947 4.48 US$116,185
2026-05-20 2026-05-18 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
3,342 -1.0%
5.06
US$16,927 		3,342 -1.0% 5.06 US$16,927
2026-05-20 2026-05-18 S Sale
2.5
Otero Jose Manuel

Chief Operating Officer

Officer
1,302 -1.0%
5.07
US$6,606 		1,302 -1.0% 5.07 US$6,606
2026-05-18 2026-05-18 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
3,342
5.06
US$16,927 		3,342 5.06 US$16,927
2026-05-18 2026-05-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
1,595
5.06
US$8,074 		1,595 5.06 US$8,074
2026-05-18 2026-05-18 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
1,302
5.07
US$6,606 		1,302 5.07 US$6,606
2026-04-07 2026-04-06 PlS Planned sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
55,000 -13.9%
5.69
US$313,137 		55,000 -13.9% 5.69 US$313,137
2026-04-06 2026-04-06 PrS Proposed sale
3.6
Richard Nolan Townsend

Director; Officer

Executive Director
55,000
5.72
US$314,600 		55,000 5.72 US$314,600
2026-02-20 2026-02-18 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
10,173 -2.5%
6.38
US$64,924 		10,173 -2.5% 6.38 US$64,924
2026-02-20 2026-02-18 S Sale
2.5
Otero Jose Manuel

Chief Operating Officer

Officer
3,016 -2.3%
6.40
US$19,294 		3,016 -2.3% 6.40 US$19,294
2026-02-18 2026-02-18 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
11,374
6.38
US$72,585 		11,374 6.38 US$72,585
2026-02-18 2026-02-18 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
3,016
6.40
US$19,294 		3,016 6.40 US$19,294
2026-02-18 2026-02-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
3,861
6.39
US$24,684 		3,861 6.39 US$24,684
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
4,867
6.40
US$31,135 		4,867 6.40 US$31,135
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
3,736
6.40
US$23,897 		3,736 6.40 US$23,897
2025-11-20 2025-11-18 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
386 -0.6%
9.27
US$3,578 		386 -0.6% 9.27 US$3,578
2025-11-20 2025-11-18 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
1,127 -0.5%
9.27
US$10,447 		1,127 -0.5% 9.27 US$10,447
2025-11-20 2025-11-18 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
615 -0.8%
9.27
US$5,701 		615 -0.8% 9.27 US$5,701
2025-11-20 2025-11-18 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
549 -0.8%
9.27
US$5,089 		549 -0.8% 9.27 US$5,089
2025-11-18 2025-11-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
549
9.27
US$5,092 		549 9.27 US$5,092
2025-11-18 2025-11-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
386
9.27
US$3,580 		386 9.27 US$3,580
2025-11-18 2025-11-18 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
721
9.27
US$6,687 		721 9.27 US$6,687
2025-11-18 2025-11-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
615
9.27
US$5,704 		615 9.27 US$5,704
2025-11-18 2025-11-18 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
1,127
9.27
US$10,452 		1,127 9.27 US$10,452
2025-10-17 2025-10-17 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
3,382
8.94
US$30,242 		3,382 8.94 US$30,242
2025-10-17 2025-10-17 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
2,115
8.94
US$18,913 		2,115 8.94 US$18,913
2025-10-17 2025-10-17 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
3,526
8.94
US$31,530 		3,526 8.94 US$31,530
2025-10-17 2025-10-17 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
13,133
8.94
US$117,437 		13,133 8.94 US$117,437
2025-10-17 2025-10-17 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
3,888
8.94
US$34,767 		3,888 8.94 US$34,767
2025-10-17 2025-10-17 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
44 -0.1%
9.56
US$421 		44 -0.1% 9.56 US$421
2025-10-17 2025-10-17 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
3,844 -5.5%
8.94
US$34,346 		3,844 -5.5% 8.94 US$34,346
2025-10-17 2025-10-17 S Sale
2.5
Otero Jose Manuel

Chief Technical Officer

Officer
24 -0.0%
9.56
US$229 		24 -0.0% 9.56 US$229
2025-10-17 2025-10-17 S Sale
2.5
Otero Jose Manuel

Chief Technical Officer

Officer
2,091 -3.2%
8.94
US$18,683 		2,091 -3.2% 8.94 US$18,683
2025-10-17 2025-10-17 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
40 -0.1%
9.56
US$382 		40 -0.1% 9.56 US$382
2025-10-17 2025-10-17 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
3,486 -4.8%
8.94
US$31,147 		3,486 -4.8% 8.94 US$31,147
2025-10-17 2025-10-17 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
148 -0.1%
9.56
US$1,415 		148 -0.1% 9.56 US$1,415
2025-10-17 2025-10-17 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
12,985 -5.1%
8.94
US$116,021 		12,985 -5.1% 8.94 US$116,021
2025-10-17 2025-10-17 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
38 -0.1%
9.56
US$363 		38 -0.1% 9.56 US$363
2025-10-17 2025-10-17 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
3,344 -4.4%
8.94
US$29,879 		3,344 -4.4% 8.94 US$29,879
2025-11-20 2025-08-18 S Sale
2.5
Otero Jose Manuel

Chief Technical Officer

Officer
721 -1.1%
9.27
US$6,684 		721 -1.1% 9.27 US$6,684
2025-08-20 2025-08-18 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
542 -0.9%
4.67
US$2,530 		542 -0.9% 4.67 US$2,530
2025-08-20 2025-08-18 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
2,735 -1.2%
4.67
US$12,767 		2,735 -1.2% 4.67 US$12,767
2025-08-20 2025-08-18 S Sale
2.5
Otero Jose Manuel

Chief Technical Officer

Officer
2,848 -4.5%
4.67
US$13,294 		2,848 -4.5% 4.67 US$13,294
2025-08-20 2025-08-18 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
608 -0.9%
4.67
US$2,838 		608 -0.9% 4.67 US$2,838
2025-08-20 2025-08-18 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
382 -0.6%
4.67
US$1,783 		382 -0.6% 4.67 US$1,783
2025-08-18 2025-08-18 PrS Proposed sale
2.5
Otero Jose Manuel

Officer

Officer
2,848
4.67
US$13,295 		2,848 4.67 US$13,295
2025-08-18 2025-08-18 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
608
4.67
US$2,838 		608 4.67 US$2,838
2025-08-18 2025-08-18 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
1,115
4.67
US$5,205 		1,115 4.67 US$5,205
2025-08-18 2025-08-18 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
382
4.67
US$1,783 		382 4.67 US$1,783
2025-08-18 2025-08-18 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
542
4.67
US$2,530 		542 4.67 US$2,530
2025-05-20 2025-05-16 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
521 -0.8%
2.77
US$1,445 		521 -0.8% 2.77 US$1,445
2025-05-20 2025-05-16 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
1,074 -0.5%
2.77
US$2,979 		1,074 -0.5% 2.77 US$2,979
2025-05-20 2025-05-16 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
585 -0.9%
2.77
US$1,623 		585 -0.9% 2.77 US$1,623
2025-05-20 2025-05-16 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
367 -0.6%
2.77
US$1,018 		367 -0.6% 2.77 US$1,018
2025-05-16 2025-05-16 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
1,074
2.77
US$2,980 		1,074 2.77 US$2,980
2025-05-16 2025-05-16 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
521
2.77
US$1,445 		521 2.77 US$1,445
2025-05-16 2025-05-16 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
367
2.77
US$1,018 		367 2.77 US$1,018
2025-05-16 2025-05-16 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
585
2.77
US$1,623 		585 2.77 US$1,623
2025-02-21 2025-02-19 S Sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
4,326 -1.9%
4.41
US$19,091 		4,326 -1.9% 4.41 US$19,091
2025-02-21 2025-02-19 S Sale
3.4
Robertson Jenny

Chief Legal Officer

Officer
2,101 -3.5%
4.41
US$9,272 		2,101 -3.5% 4.41 US$9,272
2025-02-21 2025-02-19 S Sale
3.3
See Tai Sandi

Chief Development Officer

Officer
1,486 -2.7%
4.41
US$6,558 		1,486 -2.7% 4.41 US$6,558
2025-02-21 2025-02-19 S Sale
3.4
Adler Eric

Chief Medical Officer

Officer
2,359 -3.3%
4.41
US$10,410 		2,359 -3.3% 4.41 US$10,410
2025-02-19 2025-02-19 PrS Proposed sale
3.6
Townsend Richard Nolan

Officer; Director

Executive Director
4,326
4.41
US$19,091 		4,326 4.41 US$19,091
2025-02-19 2025-02-19 PrS Proposed sale
3.4
Robertson Jenny

Officer

Officer
2,101
4.41
US$9,272 		2,101 4.41 US$9,272
2025-02-19 2025-02-19 PrS Proposed sale
3.3
See Tai Sandi

Officer

Officer
1,486
4.41
US$6,558 		1,486 4.41 US$6,558
2025-02-19 2025-02-19 PrS Proposed sale
3.4
Adler Eric

Officer

Officer
2,359
4.41
US$10,410 		2,359 4.41 US$10,410
2024-12-12 2024-12-10 PlS Planned sale
3.6
Townsend Richard Nolan

Chief Executive Officer

Executive Director
2,500 -2.0%
8.20
US$20,491 		2,500 -2.0% 8.20 US$20,491
2024-12-10 2024-12-10 PrS Proposed sale
3.6
Richard Nolan Townsend

Director; Officer

Executive Director
2,500
8.24
US$20,600 		2,500 8.24 US$20,600
Explore more

More insider trading research around Lexeo Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America